Details for: ACTN4

Gene ID: 81

Gene Type:  Protein-coding  - A gene that serves as a template for producing a messenger RNA (mRNA) molecule, which is then translated into a functional protein.

Symbol: ACTN4

Ensembl ID: ENSG00000130402

Description: actinin alpha 4

Selected Context(s):  Overall

Cell Significance Landscape

Contexts:

Associated with

Significant Cells

Cell Significance Index (CSI) scores for the chosen context(s)

  • colon epithelial cell CL0011108
    CSI 67.03
    rCSI 70.21%
    PRS 8.41
  • BEST4+ enteroycte CL4030026
    CSI 64.66
    rCSI 80.42%
    PRS 9.62
  • conjunctival epithelial cell CL1000432
    CSI 58.61
    rCSI 89.52%
    PRS 9.07
  • fallopian tube secretory epithelial cell CL4030006
    CSI 56.12
    rCSI 54.02%
    PRS 9.36
  • stem cell CL0000034
    CSI 50.97
    rCSI 49.14%
    PRS 5.92
  • intestine goblet cell CL0019031
    CSI 50.31
    rCSI 44.66%
    PRS 9.05
  • enterocyte CL0000584
    CSI 44.33
    rCSI 71.49%
    PRS 14.48
  • multi-ciliated epithelial cell CL0005012
    CSI 44
    rCSI 43.91%
    PRS 7.76
  • M cell of gut CL0000682
    CSI 42.71
    rCSI 45.38%
    PRS 16.15
  • goblet cell CL0000160
    CSI 42.23
    rCSI 39.9%
    PRS 9.44
  • transit amplifying cell of colon CL0009011
    CSI 41.59
    rCSI 48.85%
    PRS 10.77
  • ciliated epithelial cell CL0000067
    CSI 41.23
    rCSI 36.26%
    PRS 6.56
  • small intestine goblet cell CL1000495
    CSI 37.71
    rCSI 82.59%
    PRS 12.19
  • extravillous trophoblast CL0008036
    CSI 37.48
    rCSI 46.36%
    PRS 7.93
  • pancreatic ductal cell CL0002079
    CSI 36.92
    rCSI 71.8%
    PRS 9.22
  • nasal mucosa goblet cell CL0002480
    CSI 35.52
    rCSI 41.2%
    PRS 13.46
  • lung ciliated cell CL1000271
    CSI 35.05
    rCSI 40.53%
    PRS 6.62
  • colonocyte CL1000347
    CSI 34.95
    rCSI 50.1%
    PRS 12.41
  • transit amplifying cell CL0009010
    CSI 33.73
    rCSI 51.59%
    PRS 14.71
  • respiratory suprabasal cell CL4033048
    CSI 32.83
    rCSI 42.1%
    PRS 10.43
  • cerebral cortex endothelial cell CL1001602
    CSI 31.45
    rCSI 54.4%
    PRS 6.91
  • keratinocyte CL0000312
    CSI 29.44
    rCSI 24.68%
    PRS 10.82
  • colon goblet cell CL0009039
    CSI 29.11
    rCSI 69.2%
    PRS 13.59
  • intestinal epithelial cell CL0002563
    CSI 28.79
    rCSI 30.09%
    PRS 9.55
  • foveolar cell of stomach CL0002179
    CSI 28.56
    rCSI 60.79%
    PRS 14.61
  • kidney loop of Henle thin ascending limb epithelial cell CL1001107
    CSI 27.9
    rCSI 72.11%
    PRS 8.44
  • myoepithelial cell CL0000185
    CSI 26.32
    rCSI 66.58%
    PRS 11.29
  • endothelial cell of artery CL1000413
    CSI 26.08
    rCSI 38.21%
    PRS 46.47
  • intrahepatic cholangiocyte CL0002538
    CSI 25.95
    rCSI 62.27%
    PRS 16.76
  • enteroendocrine cell of small intestine CL0009006
    CSI 24.81
    rCSI 54.62%
    PRS 13.87
  • perivascular cell CL4033054
    CSI 24.6
    rCSI 33.63%
    PRS 10.28
  • intestinal crypt stem cell of small intestine CL0009017
    CSI 24.31
    rCSI 65.54%
    PRS 11.68
  • epithelial cell CL0000066
    CSI 24.31
    rCSI 37.35%
    PRS 12.98
  • retinal blood vessel endothelial cell CL0002585
    CSI 23.97
    rCSI 38.28%
    PRS 9.86
  • smooth muscle cell CL0000192
    CSI 23.76
    rCSI 56.65%
    PRS 29.13
  • corneal epithelial cell CL0000575
    CSI 23.67
    rCSI 67.71%
    PRS 16.69
  • podocyte CL0000653
    CSI 23.45
    rCSI 100%
    PRS 9.03
  • placental villous trophoblast CL2000060
    CSI 23.37
    rCSI 36.12%
    PRS 8.47
  • pancreatic acinar cell CL0002064
    CSI 23.06
    rCSI 30.65%
    PRS 9.86
  • basal-myoepithelial cell of mammary gland CL0002324
    CSI 22.56
    rCSI 42.64%
    PRS 19.88
  • microcirculation associated smooth muscle cell CL0008035
    CSI 22.35
    rCSI 64.71%
    PRS 10.25
  • enteric smooth muscle cell CL0002504
    CSI 22.02
    rCSI 31.42%
    PRS 10.23
  • blood vessel endothelial cell CL0000071
    CSI 21.47
    rCSI 44.54%
    PRS 9.03
  • glandular epithelial cell CL0000150
    CSI 21.13
    rCSI 55.63%
    PRS 17.74
  • kidney loop of Henle thin descending limb epithelial cell CL1001111
    CSI 20.54
    rCSI 29.11%
    PRS 8.5
  • tracheal goblet cell CL1000329
    CSI 20.2
    rCSI 44.1%
    PRS 18.4
  • type EC enteroendocrine cell CL0000577
    CSI 20
    rCSI 71%
    PRS 14.84
  • type L enteroendocrine cell CL0002279
    CSI 19.72
    rCSI 37.01%
    PRS 17.91
  • epithelial cell of lower respiratory tract CL0002632
    CSI 19.64
    rCSI 15.23%
    PRS 8.63
  • epithelial cell of proximal tubule CL0002306
    CSI 19.24
    rCSI 47%
    PRS 9.15
  • paneth cell of epithelium of small intestine CL1000343
    CSI 18.85
    rCSI 52.83%
    PRS 14.07
  • deuterosomal cell CL4033044
    CSI 18.78
    rCSI 63.48%
    PRS 15.5
  • cardiac muscle cell CL0000746
    CSI 18.7
    rCSI 26.83%
    PRS 7.19
  • duct epithelial cell CL0000068
    CSI 18.41
    rCSI 26.93%
    PRS 9.57
  • L2/3-6 intratelencephalic projecting glutamatergic neuron CL4023040
    CSI 18.08
    rCSI 43.94%
    PRS 5.18
  • renal interstitial pericyte CL1001318
    CSI 17.95
    rCSI 49.48%
    PRS 8.94
  • club cell CL0000158
    CSI 17.06
    rCSI 24.98%
    PRS 10.59
  • endothelial cell of placenta CL0009092
    CSI 16.83
    rCSI 82.94%
    PRS 12.29
  • secretory cell CL0000151
    CSI 16.8
    rCSI 17.53%
    PRS 9.29
  • transit amplifying cell of small intestine CL0009012
    CSI 16.64
    rCSI 73.07%
    PRS 16.93
  • plasmacytoid dendritic cell, human CL0001058
    CSI 15.96
    rCSI 11.14%
    PRS 9.54
  • capillary endothelial cell CL0002144
    CSI 15.09
    rCSI 27.66%
    PRS 44.13
  • respiratory basal cell CL0002633
    CSI 14.98
    rCSI 15.52%
    PRS 10.64
  • enterocyte of epithelium of large intestine CL0002071
    CSI 14.76
    rCSI 77.51%
    PRS 16.77
  • myofibroblast cell CL0000186
    CSI 14.68
    rCSI 20.33%
    PRS 13.02
  • ciliated cell CL0000064
    CSI 14.43
    rCSI 23.37%
    PRS 9.24
  • parietal epithelial cell CL1000452
    CSI 14.37
    rCSI 38.4%
    PRS 8.27
  • basal cell of prostate epithelium CL0002341
    CSI 14.28
    rCSI 41.31%
    PRS 20.29
  • squamous epithelial cell CL0000076
    CSI 14.15
    rCSI 33.58%
    PRS 11.79
  • epithelial cell of lung CL0000082
    CSI 13.87
    rCSI 11.5%
    PRS 8.58
  • mucous neck cell CL0000651
    CSI 13.85
    rCSI 19.96%
    PRS 14.6
  • pulmonary capillary endothelial cell CL4028001
    CSI 12.93
    rCSI 24.66%
    PRS 14.54
  • renal principal cell CL0005009
    CSI 12.83
    rCSI 33.34%
    PRS 12.57
  • kidney connecting tubule epithelial cell CL1000768
    CSI 12.83
    rCSI 32.55%
    PRS 7.01
  • respiratory hillock cell CL4030023
    CSI 12.57
    rCSI 22.41%
    PRS 15.45
  • lung endothelial cell CL1001567
    CSI 12.49
    rCSI 29.12%
    PRS 22.17
  • basal cell CL0000646
    CSI 12.07
    rCSI 16.15%
    PRS 9.87
  • pulmonary artery endothelial cell CL1001568
    CSI 11.86
    rCSI 16.14%
    PRS 13.88
  • CD16-negative, CD56-bright natural killer cell, human CL0000938
    CSI 11.61
    rCSI 8.71%
    PRS 26.55
  • mammary gland epithelial cell CL0002327
    CSI 11.41
    rCSI 40.03%
    PRS 16.41
  • class switched memory B cell CL0000972
    CSI 11.3
    rCSI 8.43%
    PRS 15.28
  • vascular leptomeningeal cell CL4023051
    CSI 11.17
    rCSI 19.58%
    PRS 6.66
  • endothelial cell of arteriole CL1000412
    CSI 11.15
    rCSI 61.88%
    PRS 31.18
  • tuft cell of colon CL0009041
    CSI 10.55
    rCSI 24.58%
    PRS 20.29
  • activated type II NK T cell CL0000931
    CSI 10.44
    rCSI 11.74%
    PRS 14.64
  • enteroendocrine cell of colon CL0009042
    CSI 10.25
    rCSI 48.04%
    PRS 24.61
  • endothelial cell of uterus CL0009095
    CSI 10.21
    rCSI 74.68%
    PRS 25.25
  • vascular associated smooth muscle cell CL0000359
    CSI 10.14
    rCSI 32.89%
    PRS 11.09
  • brush cell of tracheobronchial tree CL0002075
    CSI 10.05
    rCSI 29.84%
    PRS 14.2
  • stromal cell of ovary CL0002132
    CSI 10
    rCSI 27.47%
    PRS 15.08
  • T-helper 17 cell CL0000899
    CSI 9.64
    rCSI 7.65%
    PRS 15.94
  • common dendritic progenitor CL0001029
    CSI 9.56
    rCSI 12%
    PRS 11.54
  • pancreatic D cell CL0000173
    CSI 9.34
    rCSI 9.18%
    PRS 9.82
  • promonocyte CL0000559
    CSI 9.14
    rCSI 15.65%
    PRS 12.14
  • CD16-positive, CD56-dim natural killer cell, human CL0000939
    CSI 9.13
    rCSI 6.09%
    PRS 24.64
  • syncytiotrophoblast cell CL0000525
    CSI 9.09
    rCSI 26.18%
    PRS 17.97
  • Mueller cell CL0000636
    CSI 8.93
    rCSI 20.37%
    PRS 8.16
  • intestinal crypt stem cell of colon CL0009043
    CSI 8.57
    rCSI 64.39%
    PRS 16.79
  • smooth muscle cell of the pulmonary artery CL0002591
    CSI 8.53
    rCSI 65.39%
    PRS 38.82
  • plasmablast CL0000980
    CSI 8.45
    rCSI 6.65%
    PRS 10.78
  • lung neuroendocrine cell CL1000223
    CSI -10.7
    rCSI -15.9%
    PRS 10.4%
  • germinal center B cell CL0000844
    CSI -8.1
    rCSI -24.1%
    PRS 23.4%
  • sncg GABAergic cortical interneuron CL4023015
    CSI -7.2
    rCSI -11.5%
    PRS 5.9%
  • lamp5 GABAergic cortical interneuron CL4023011
    CSI -6.0
    rCSI -10.1%
    PRS 5.3%
  • chandelier pvalb GABAergic cortical interneuron CL4023036
    CSI -5.8
    rCSI -18.1%
    PRS 6.2%
  • cardiac neuron CL0010022
    CSI -4.2
    rCSI -13.5%
    PRS 6.5%
  • neuroblast (sensu Vertebrata) CL0000031
    CSI -3.9
    rCSI -5.0%
    PRS 8.8%
  • near-projecting glutamatergic cortical neuron CL4023012
    CSI -3.7
    rCSI -13.9%
    PRS 5.5%
  • inflammatory macrophage CL0000863
    CSI -2.5
    rCSI -4.3%
    PRS 18.4%
  • CD14-positive, CD16-positive monocyte CL0002397
    CSI -2.5
    rCSI -3.3%
    PRS 12.6%
  • platelet CL0000233
    CSI -1.1
    rCSI -4.6%
    PRS 21.8%
  • retinal cone cell CL0000573
    CSI -1.1
    rCSI -1.8%
    PRS 6.9%
  • fibroblast of cardiac tissue CL0002548
    CSI -1.0
    rCSI -4.7%
    PRS 5.7%
  • mesenchymal cell CL0008019
    CSI -1.0
    rCSI -2.5%
    PRS 9.2%
  • central nervous system neuron CL2000029
    CSI -0.5
    rCSI -3.7%
    PRS 4.3%
  • L6b glutamatergic cortical neuron CL4023038
    CSI -0.3
    rCSI -0.9%
    PRS 5.7%
  • T-helper 1 cell CL0000545
    CSI -0.1
    rCSI -0.2%
    PRS 25.6%
  • lymphoid lineage restricted progenitor cell CL0000838
    CSI 0.1
    rCSI 0.2%
    PRS 15.0%
  • medium spiny neuron CL1001474
    CSI 0.1
    rCSI 0.7%
    PRS 2.1%
  • cytotoxic T cell CL0000910
    CSI 0.1
    rCSI 0.6%
    PRS 13.6%
  • amacrine cell CL0000561
    CSI 0.1
    rCSI 0.3%
    PRS 7.3%
  • pre-conventional dendritic cell CL0002010
    CSI 0.2
    rCSI 2.0%
    PRS 30.6%
  • Hofbauer cell CL3000001
    CSI 0.2
    rCSI 0.3%
    PRS 11.2%
  • retinal bipolar neuron CL0000748
    CSI 0.2
    rCSI 0.4%
    PRS 6.7%
  • enteric neuron CL0007011
    CSI 0.2
    rCSI 3.6%
    PRS 24.1%
  • metallothionein-positive alveolar macrophage CL4033042
    CSI 0.3
    rCSI 2.7%
    PRS 38.3%
  • regular ventricular cardiac myocyte CL0002131
    CSI 0.3
    rCSI 1.7%
    PRS 7.2%
  • Merkel cell CL0000242
    CSI 0.4
    rCSI 8.4%
    PRS 57.8%
  • OFF midget ganglion cell CL4033047
    CSI 0.4
    rCSI 7.5%
    PRS 8.1%
  • P/D1 enteroendocrine cell CL0002268
    CSI 0.4
    rCSI 2.1%
    PRS 22.9%
  • erythroblast CL0000765
    CSI 0.4
    rCSI 1.0%
    PRS 15.2%
  • choroid plexus epithelial cell CL0000706
    CSI 0.4
    rCSI 0.6%
    PRS 7.0%
  • neuroendocrine cell CL0000165
    CSI 0.4
    rCSI 1.5%
    PRS 19.1%
  • paneth cell CL0000510
    CSI 0.4
    rCSI 0.6%
    PRS 14.3%
  • CD14-positive, CD16-negative classical monocyte CL0002057
    CSI 0.4
    rCSI 2.6%
    PRS 20.6%
  • retina horizontal cell CL0000745
    CSI 0.5
    rCSI 0.7%
    PRS 8.5%
  • kidney granular cell CL0000648
    CSI 0.5
    rCSI 6.5%
    PRS 52.8%
  • mesenchymal stem cell CL0000134
    CSI 0.5
    rCSI 5.7%
    PRS 16.5%
  • effector memory CD8-positive, alpha-beta T cell, terminally differentiated CL0001062
    CSI 0.5
    rCSI 2.6%
    PRS 11.9%
  • cardiac blood vessel endothelial cell CL0010006
    CSI 0.5
    rCSI 3.8%
    PRS 11.3%
  • erythroid progenitor cell CL0000038
    CSI 0.6
    rCSI 3.2%
    PRS 14.2%
  • lung macrophage CL1001603
    CSI 0.6
    rCSI 1.4%
    PRS 10.2%
  • smooth muscle cell of prostate CL1000487
    CSI 0.7
    rCSI 3.8%
    PRS 41.7%
  • caudal ganglionic eminence derived cortical interneuron CL4023064
    CSI 0.7
    rCSI 1.2%
    PRS 5.3%
  • mesangial cell CL0000650
    CSI 0.7
    rCSI 2.9%
    PRS 12.7%
  • ON midget ganglion cell CL4033046
    CSI 0.7
    rCSI 14.4%
    PRS 7.3%
  • megakaryocyte-erythroid progenitor cell CL0000050
    CSI 0.7
    rCSI 0.6%
    PRS 8.0%
  • cerebellar granule cell CL0001031
    CSI 0.8
    rCSI 1.1%
    PRS 8.6%
  • large pre-B-II cell CL0000957
    CSI 0.8
    rCSI 2.3%
    PRS 16.0%
  • peripheral nervous system neuron CL2000032
    CSI 0.8
    rCSI 1.2%
    PRS 8.1%
  • endocardial cell CL0002350
    CSI 0.9
    rCSI 4.1%
    PRS 12.6%
  • group 2 innate lymphoid cell CL0001069
    CSI 0.9
    rCSI 4.8%
    PRS 31.1%
  • uterine smooth muscle cell CL0002601
    CSI 0.9
    rCSI 5.9%
    PRS 55.6%
  • fraction A pre-pro B cell CL0002045
    CSI 0.9
    rCSI 1.0%
    PRS 18.7%
  • myelocyte CL0002193
    CSI 0.9
    rCSI 6.0%
    PRS 30.1%
  • basophil CL0000767
    CSI 0.9
    rCSI 1.9%
    PRS 19.1%
  • myeloid lineage restricted progenitor cell CL0000839
    CSI 0.9
    rCSI 4.8%
    PRS 18.1%
  • colon macrophage CL0009038
    CSI 0.9
    rCSI 4.4%
    PRS 19.3%
  • myeloid dendritic cell, human CL0001057
    CSI 1.0
    rCSI 5.5%
    PRS 28.8%
  • astrocyte of the cerebral cortex CL0002605
    CSI 1.0
    rCSI 2.3%
    PRS 5.6%
  • serous secreting cell of bronchus submucosal gland CL4033005
    CSI 1.0
    rCSI 5.9%
    PRS 38.4%
  • dopaminergic neuron CL0000700
    CSI 1.1
    rCSI 5.9%
    PRS 3.3%
  • skeletal muscle satellite cell CL0000594
    CSI 1.1
    rCSI 3.1%
    PRS 32.3%
  • hair follicular keratinocyte CL2000092
    CSI 1.1
    rCSI 18.7%
    PRS 36.9%
  • ventricular cardiac muscle cell CL2000046
    CSI 1.1
    rCSI 3.7%
    PRS 37.4%
  • L4 intratelencephalic projecting glutamatergic neuron CL4030063
    CSI 1.1
    rCSI 2.7%
    PRS 4.8%
  • pancreatic stellate cell CL0002410
    CSI 1.1
    rCSI 6.6%
    PRS 13.6%
  • CD4-positive, alpha-beta cytotoxic T cell CL0000934
    CSI 1.1
    rCSI 1.6%
    PRS 19.1%
  • primitive red blood cell CL0002355
    CSI 1.2
    rCSI 6.3%
    PRS 17.2%
  • peptic cell CL0000155
    CSI 1.2
    rCSI 11.8%
    PRS 27.7%
  • early lymphoid progenitor CL0000936
    CSI 1.2
    rCSI 1.1%
    PRS 10.2%
  • CD34-positive, CD56-positive, CD117-positive common innate lymphoid precursor, human CL0001074
    CSI 1.2
    rCSI 14.1%
    PRS 36.1%
  • airway submucosal gland duct basal cell CL4033024
    CSI 1.3
    rCSI 8.0%
    PRS 32.0%
  • endothelial cell of periportal hepatic sinusoid CL0019021
    CSI 1.3
    rCSI 5.7%
    PRS 28.0%
  • epicardial adipocyte CL1000309
    CSI 1.4
    rCSI 4.4%
    PRS 12.2%
  • retinal ganglion cell CL0000740
    CSI 1.4
    rCSI 3.0%
    PRS 6.5%
  • kidney distal convoluted tubule epithelial cell CL1000849
    CSI 1.4
    rCSI 14.7%
    PRS 13.5%
  • Langerhans cell CL0000453
    CSI 1.5
    rCSI 2.4%
    PRS 15.8%
  • common lymphoid progenitor CL0000051
    CSI 1.5
    rCSI 2.1%
    PRS 17.3%
  • radial glial cell CL0000681
    CSI 1.6
    rCSI 2.2%
    PRS 9.4%
  • fibroblast of breast CL4006000
    CSI 1.6
    rCSI 6.7%
    PRS 24.2%
  • innate lymphoid cell CL0001065
    CSI 1.6
    rCSI 3.3%
    PRS 14.2%
  • bronchiolar smooth muscle cell CL4033017
    CSI 1.6
    rCSI 24.2%
    PRS 29.5%
  • L5/6 near-projecting glutamatergic neuron CL4030067
    CSI 1.6
    rCSI 5.3%
    PRS 4.3%
  • midzonal region hepatocyte CL0019028
    CSI 1.6
    rCSI 3.8%
    PRS 14.6%
  • sst GABAergic cortical interneuron CL4023017
    CSI 1.6
    rCSI 2.1%
    PRS 5.7%
  • epithelial cell of esophagus CL0002252
    CSI 1.7
    rCSI 16.4%
    PRS 34.2%
  • elicited macrophage CL0000861
    CSI 1.7
    rCSI 1.5%
    PRS 10.3%
  • centrilobular region hepatocyte CL0019029
    CSI 1.7
    rCSI 4.4%
    PRS 15.1%
  • brush cell CL0002204
    CSI 1.7
    rCSI 3.4%
    PRS 24.9%
  • adventitial cell CL0002503
    CSI 1.7
    rCSI 4.1%
    PRS 14.4%
  • retinal pigment epithelial cell CL0002586
    CSI 1.7
    rCSI 3.5%
    PRS 9.7%
  • mucus secreting cell CL0000319
    CSI 1.8
    rCSI 2.8%
    PRS 11.7%
  • CD8-positive, alpha-beta cytotoxic T cell CL0000794
    CSI 1.8
    rCSI 2.1%
    PRS 15.8%
  • mesodermal cell CL0000222
    CSI 1.8
    rCSI 2.2%
    PRS 9.0%
  • CD8-positive, alpha-beta memory T cell, CD45RO-positive CL0001203
    CSI 1.8
    rCSI 2.2%
    PRS 12.7%
  • alternatively activated macrophage CL0000890
    CSI 1.8
    rCSI 2.3%
    PRS 13.9%
  • glioblast CL0000030
    CSI 1.9
    rCSI 3.0%
    PRS 7.8%
  • respiratory epithelial cell CL0002368
    CSI 1.9
    rCSI 11.9%
    PRS 29.8%
  • eosinophil CL0000771
    CSI 1.9
    rCSI 12.7%
    PRS 23.8%

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this specific cell.

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.
Network Configuration

Explore relationships of the current gene. Select an Interaction Source: 'ONTOLOGY' for shared pathways (GO/Reactome) or 'STRING' for protein-protein interactions. Further refine by selecting context genes and comparing Cell Significance Index (CSI) scores between baseline and target cell types and their specific contexts.

Comma-separated if multiple.
Comma-separated if multiple.

Legend:
  • Query Gene
  • Node Color (Target Cell CSI, relative to current network):
    • Very High
    • High
    • Medium
    • Low
    • Very Low
    • CSI N/A
  • Node Size: Proportional to Target Cell CSI magnitude
  • STRING PPI Edge
  • Shared Pathway Edge (ONTOLOGY)

Loading network (please wait)...

Other Information

This section provides additional information about the gene, including a description generated by an AI language model and details about associated proteins.

## Summary [ACTN4](/details-gene/81) (actinin alpha 4) is a protein-coding gene located on chromosome 19q13.2. It encodes a non-muscle, actin-binding protein that plays a crucial role in cytoskeleton organization, cell motility, and adhesion. Functionally, [ACTN4](/details-gene/81) is involved in crosslinking actin filaments and anchoring them to the cell membrane and focal adhesions. Expression data reveals its high significance primarily in various epithelial cell types, such as [colon epithelial cell](/details-cell/CL0011108) and [BEST4+ enteroycte](/details-cell/CL4030026), suggesting a fundamental role in maintaining the structural integrity and dynamic properties of epithelial tissues. Beyond its structural functions, it also acts as a transcriptional coactivator in the nucleus, linking mechanical signals from the cytoskeleton to gene regulation. ## Cellular Roles and Expression Landscape The expression profile of [ACTN4](/details-gene/81) underscores its importance as a key structural protein in epithelial tissues. **Overall**, the gene shows the highest significance in a range of epithelial cells lining various organs. It is a top marker in [colon epithelial cell](/details-cell/CL0011108) (CSI: 67.03), [BEST4+ enteroycte](/details-cell/CL4030026) (CSI: 64.66), [conjunctival epithelial cell](/details-cell/CL1000432) (CSI: 58.61), and [fallopian tube secretory epithelial cell](/details-cell/CL4030006) (CSI: 56.12). Its high expression is also noted in secretory cells like [intestine goblet cell](/details-cell/CL0019031) and proliferative populations such as [transit amplifying cell of colon](/details-cell/CL0009011), indicating a role in both stable barrier function and tissue renewal. Conversely, the gene's expression is notably low or absent in cells of the nervous system and hematopoietic lineage. It is a significant anti-marker for neuronal populations, including [sncg GABAergic cortical interneuron](/details-cell/CL4023015) (CSI: -7.17) and [cardiac neuron](/details-cell/CL0010022) (CSI: -4.21), as well as specific immune cells like [germinal center B cell](/details-cell/CL0000844) (CSI: -8.09) and [inflammatory macrophage](/details-cell/CL0000863) (CSI: -2.52). This restricted expression pattern suggests a highly specialized function for [ACTN4](/details-gene/81) in cytoskeletal dynamics specific to non-neuronal and non-hematopoietic tissues, particularly in maintaining the architecture of epithelial layers. ## Pathways and Molecular Function The functions of [ACTN4](/details-gene/81) are well-aligned with its cellular expression pattern. As an actin-binding protein, it is a central component of the [Actin cytoskeleton](/details-ontology/GO:0015629), localizing to structures such as [Focal adhesion](/details-ontology/GO:0005925) and [Stress fiber](/details-ontology/GO:0001725). Its molecular functions include [Actin binding](/details-ontology/GO:0003779) and [Integrin binding](/details-ontology/GO:0005178), which are critical for linking the cytoskeleton to the extracellular matrix and mediating cell adhesion and migration. This is consistent with its role in biological processes like [Actin cytoskeleton organization](/details-ontology/GO:0030036) and [Positive regulation of cell migration](/details-ontology/GO:0030335), as highlighted by research linking it to cell motility and cancer invasion ([Link](https://doi.org/10.1083/jcb.140.6.1383)). Beyond its canonical structural role, [ACTN4](/details-gene/81) also functions in the [Nucleus](/details-ontology/GO:0005634) as a [Transcription coactivator](/details-ontology/GO:0003713), where it can engage in [Chromatin dna binding](/details-ontology/GO:0031490) and interact with nuclear receptors ([Nuclear receptor binding](/details-ontology/GO:0016922)). This dual localization suggests it may function as a mechanosensor, shuttling between the cytoplasm and nucleus to translate physical cues into changes in gene expression. The gene is also implicated in signaling pathways such as the [Tumor necrosis factor-mediated signaling pathway](/details-ontology/GO:0033209). In a broader context, its involvement in the Reactome pathway [Cell-cell communication](/details-pathway/R-HSA-1500931) reinforces its importance in maintaining tissue coherence, a role paramount in the epithelial cell types where it is most prominently expressed. ## Research Directions The dual function of [ACTN4](/details-gene/81) as both a structural protein and a nuclear regulator presents compelling avenues for future research, particularly in the context of disease pathogenesis. Its high expression in epithelial cells, coupled with its known role in cell migration, makes it a gene of significant interest in cancer biology. **Proposed Hypotheses:** 1. Mechanical stress or loss of cell-cell contacts in epithelial tissues, such as during the initial stages of tumorigenesis, induces the nuclear translocation of [ACTN4](/details-gene/81). Once in the nucleus, it acts as a transcriptional co-activator for genes that drive the epithelial-mesenchymal transition (EMT), thereby promoting cell invasion and metastasis. 2. Mutations or post-translational modifications of [ACTN4](/details-gene/81) associated with cancer disrupt its homodimerization ([Protein homodimerization activity](/details-ontology/GO:0042803)), leading to aberrant actin bundling. This results in altered cell stiffness and increased migratory capacity, facilitating the escape of cancer cells from the primary tumor. **Experimental Approach:** To test the first hypothesis, one could utilize a 3D organoid model of [colon epithelial cell](/details-cell/CL0011108)s. Applying mechanical stress (e.g., stretching the substrate) or treating the organoids with EMT-inducing factors (e.g., TGF-β) would serve as the stimulus. The subcellular localization of [ACTN4](/details-gene/81) could be tracked using immunofluorescence microscopy and quantified via cell fractionation followed by western blotting. To establish a causal link to gene expression, chromatin immunoprecipitation sequencing (ChIP-seq) could be performed to identify the genomic binding sites of nuclear [ACTN4](/details-gene/81), followed by RNA-sequencing to correlate its binding with changes in the expression of target genes involved in EMT. **Therapeutic Potential:** Given its documented association with cancer invasion ([Link](https://doi.org/10.1083/jcb.140.6.1383)) and its role in promoting cell motility, [ACTN4](/details-gene/81) represents a potential therapeutic target for metastatic cancers. As an intracellular protein, the most viable strategy would likely involve the development of small molecule inhibitors. Such compounds could be designed to interfere with its actin-binding domain, preventing cytoskeletal reorganization, or to block its nuclear import, thereby disrupting its function as a transcriptional co-activator. Therefore, **inhibition** of [ACTN4](/details-gene/81) function, rather than activation, would be the desired therapeutic outcome to reduce cancer cell migration and invasion.

Genular Protein ID: 135020461

Symbol: ACTN4_HUMAN

Name: N/A

UniProtKB Accession Codes:

Database IDs:

Citations:

PubMed ID: 10656685

Title: The human non-muscle alpha-actinin protein encoded by the ACTN4 gene suppresses tumorigenicity of human neuroblastoma cells.

PubMed ID: 10656685

DOI: 10.1038/sj.onc.1203310

PubMed ID: 22567897

Title: Novel splicing isoform of actin-binding protein alpha-actinin 4 in epidermoid carcinoma cells A431.

PubMed ID: 22567897

PubMed ID: 15057824

Title: The DNA sequence and biology of human chromosome 19.

PubMed ID: 15057824

DOI: 10.1038/nature02399

PubMed ID: 15489334

Title: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).

PubMed ID: 15489334

DOI: 10.1101/gr.2596504

PubMed ID: 17974005

Title: The full-ORF clone resource of the German cDNA consortium.

PubMed ID: 17974005

DOI: 10.1186/1471-2164-8-399

PubMed ID: 16344560

Title: Diversification of transcriptional modulation: large-scale identification and characterization of putative alternative promoters of human genes.

PubMed ID: 16344560

DOI: 10.1101/gr.4039406

PubMed ID: 9508771

Title: Actinin-4, a novel actin-bundling protein associated with cell motility and cancer invasion.

PubMed ID: 9508771

DOI: 10.1083/jcb.140.6.1383

PubMed ID: 12042308

Title: Interaction of two actin-binding proteins, synaptopodin and alpha-actinin-4, with the tight junction protein MAGI-1.

PubMed ID: 12042308

DOI: 10.1074/jbc.m203072200

PubMed ID: 15772161

Title: CART: an Hrs/actinin-4/BERP/myosin V protein complex required for efficient receptor recycling.

PubMed ID: 15772161

DOI: 10.1091/mbc.e04-11-1014

PubMed ID: 17289661

Title: Molecular composition of IMP1 ribonucleoprotein granules.

PubMed ID: 17289661

DOI: 10.1074/mcp.m600346-mcp200

PubMed ID: 19608861

Title: Lysine acetylation targets protein complexes and co-regulates major cellular functions.

PubMed ID: 19608861

DOI: 10.1126/science.1175371

PubMed ID: 21269460

Title: Initial characterization of the human central proteome.

PubMed ID: 21269460

DOI: 10.1186/1752-0509-5-17

PubMed ID: 22689882

Title: EWI-2 association with alpha-actinin regulates T cell immune synapses and HIV viral infection.

PubMed ID: 22689882

DOI: 10.4049/jimmunol.1103708

PubMed ID: 24275569

Title: An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.

PubMed ID: 24275569

DOI: 10.1016/j.jprot.2013.11.014

PubMed ID: 25944712

Title: N-terminome analysis of the human mitochondrial proteome.

PubMed ID: 25944712

DOI: 10.1002/pmic.201400617

PubMed ID: 33228246

Title: ACTN4 Mediates SEPT14 Mutation-Induced Sperm Head Defects.

PubMed ID: 33228246

DOI: 10.3390/biomedicines8110518

PubMed ID: 15988023

Title: Structural dynamics of alpha-actinin-vinculin interactions.

PubMed ID: 15988023

DOI: 10.1128/mcb.25.14.6112-6122.2005

PubMed ID: 18164029

Title: Crystal structure of the actin-binding domain of alpha-actinin-4 Lys255Glu mutant implicated in focal segmental glomerulosclerosis.

PubMed ID: 18164029

DOI: 10.1016/j.jmb.2007.11.084

PubMed ID: 22351778

Title: Familial focal segmental glomerulosclerosis (FSGS)-linked alpha-actinin 4 (ACTN4) protein mutants lose ability to activate transcription by nuclear hormone receptors.

PubMed ID: 22351778

DOI: 10.1074/jbc.m112.345421

PubMed ID: 10700177

Title: Mutations in ACTN4, encoding alpha-actinin-4, cause familial focal segmental glomerulosclerosis.

PubMed ID: 10700177

DOI: 10.1038/73456

PubMed ID: 18436095

Title: Familial focal segmental glomerulosclerosis associated with an ACTN4 mutation and paternal germline mosaicism.

PubMed ID: 18436095

DOI: 10.1053/j.ajkd.2008.01.018

PubMed ID: 22732337

Title: Mutations in podocyte genes are a rare cause of primary FSGS associated with ESRD in adult patients.

PubMed ID: 22732337

DOI: 10.5414/cn107320

PubMed ID: 23890478

Title: Mutational analysis of ACTN4, encoding alpha-actinin 4, in patients with focal segmental glomerulosclerosis using HRM method.

PubMed ID: 23890478

PubMed ID: 23014460

Title: Mutations in the INF2 gene account for a significant proportion of familial but not sporadic focal and segmental glomerulosclerosis.

PubMed ID: 23014460

DOI: 10.1038/ki.2012.349

Sequence Information:

  • Length: 911
  • Mass: 104854
  • Checksum: 461580C3F22937D1
  • Sequence:
  • MVDYHAANQS YQYGPSSAGN GAGGGGSMGD YMAQEDDWDR DLLLDPAWEK QQRKTFTAWC 
    NSHLRKAGTQ IENIDEDFRD GLKLMLLLEV ISGERLPKPE RGKMRVHKIN NVNKALDFIA 
    SKGVKLVSIG AEEIVDGNAK MTLGMIWTII LRFAIQDISV EETSAKEGLL LWCQRKTAPY 
    KNVNVQNFHI SWKDGLAFNA LIHRHRPELI EYDKLRKDDP VTNLNNAFEV AEKYLDIPKM 
    LDAEDIVNTA RPDEKAIMTY VSSFYHAFSG AQKAETAANR ICKVLAVNQE NEHLMEDYEK 
    LASDLLEWIR RTIPWLEDRV PQKTIQEMQQ KLEDFRDYRR VHKPPKVQEK CQLEINFNTL 
    QTKLRLSNRP AFMPSEGKMV SDINNGWQHL EQAEKGYEEW LLNEIRRLER LDHLAEKFRQ 
    KASIHEAWTD GKEAMLKHRD YETATLSDIK ALIRKHEAFE SDLAAHQDRV EQIAAIAQEL 
    NELDYYDSHN VNTRCQKICD QWDALGSLTH SRREALEKTE KQLEAIDQLH LEYAKRAAPF 
    NNWMESAMED LQDMFIVHTI EEIEGLISAH DQFKSTLPDA DREREAILAI HKEAQRIAES 
    NHIKLSGSNP YTTVTPQIIN SKWEKVQQLV PKRDHALLEE QSKQQSNEHL RRQFASQANV 
    VGPWIQTKME EIGRISIEMN GTLEDQLSHL KQYERSIVDY KPNLDLLEQQ HQLIQEALIF 
    DNKHTNYTME HIRVGWEQLL TTIARTINEV ENQILTRDAK GISQEQMQEF RASFNHFDKD 
    HGGALGPEEF KACLISLGYD VENDRQGEAE FNRIMSLVDP NHSGLVTFQA FIDFMSRETT 
    DTDTADQVIA SFKVLAGDKN FITAEELRRE LPPDQAEYCI ARMAPYQGPD AVPGALDYKS 
    FSTALYGESD L

Genular Protein ID: 2303997419

Symbol: H7C144_HUMAN

Name: N/A

UniProtKB Accession Codes:

Database IDs:

Citations:

PubMed ID: 11237011

Title: Initial sequencing and analysis of the human genome.

PubMed ID: 11237011

DOI: 10.1038/35057062

PubMed ID: 15057824

Title: The DNA sequence and biology of human chromosome 19.

PubMed ID: 15057824

DOI: 10.1038/nature02399

PubMed ID: 15496913

Title: Finishing the euchromatic sequence of the human genome.

PubMed ID: 15496913

DOI: 10.1038/nature03001

PubMed ID: 19608861

Title: Lysine acetylation targets protein complexes and co-regulates major cellular functions.

PubMed ID: 19608861

DOI: 10.1126/science.1175371

PubMed ID: 21269460

Title: Initial characterization of the human central proteome.

PubMed ID: 21269460

DOI: 10.1186/1752-0509-5-17

PubMed ID: 24275569

Title: An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.

PubMed ID: 24275569

DOI: 10.1016/j.jprot.2013.11.014

PubMed ID: 25944712

Title: N-terminome analysis of the human mitochondrial proteome.

PubMed ID: 25944712

Sequence Information:

  • Length: 906
  • Mass: 104327
  • Checksum: 85B7706D09DAFED7
  • Sequence:
  • MVDYHAANQS YQYGPSSAGN GAGGGGSMGD YMAQEDDWDR DLLLDPAWEK QQRKTFTAWC 
    NSHLRKAGTQ IENIDEDFRD GLKLMLLLEV ISGERLPKPE RGKMRVHKIN NVNKALDFIA 
    SKGVKLVSIG AEEIVDGNAK MTLGMIWTII LRFAIQDISV EETSAKEGLL LWCQRKTAPY 
    KNVNVQNFHI SWKDGLAFNA LIHRHRPELI EYDKLRKDDP VTNLNNAFEV AEKYLDIPKM 
    LDAEDIVGTL RPDEKAIMTY VSCFYHAFSG AQKAETAANR ICKVLAVNQE NEHLMEDYEK 
    LASDLLEWIR RTIPWLEDRV PQKTIQEMQQ KLEDFRDYRR VHKPPKVQEK CQLEINFNTL 
    QTKLRLSNRP AFMPSEGKMV SDINNGWQHL EQAEKGYEEW LLNEIRRLER LDHLAEKFRQ 
    KASIHEAWTD GKEAMLKHRD YETATLSDIK ALIRKHEAFE SDLAAHQDRV EQIAAIAQEL 
    NELDYYDSHN VNTRCQKICD QWDALGSLTH SRREALEKTE KQLEAIDQLH LEYAKRAAPF 
    NNWMESAMED LQDMFIVHTI EEIEGLISAH DQFKSTLPDA DREREAILAI HKEAQRIAES 
    NHIKLSGSNP YTTVTPQIIN SKWEKVQQLV PKRDHALLEE QSKQQSNEHL RRQFASQANV 
    VGPWIQTKME EIGRISIEMN GTLEDQLSHL KQYERSIVDY KPNLDLLEQQ HQLIQEALIF 
    DNKHTNYTME HIRVGWEQLL TTIARTINEV ENQILTRDAK GISQEQMQEF RASFNHFDKK 
    QTGSMDSDDF RALLISTGYS LGEAEFNRIM SLVDPNHSGL VTFQAFIDFM SRETTDTDTA 
    DQVIASFKVL AGDKNFITAE ELRRELPPDQ AEYCIARMAP YQGPDAVPGA LDYKSFSTAL 
    YGESDL